| CYTOSORBENTS CORP. DL-,01 |
| USA |
| Gesundheit |
| US23283X2062 / A12GDU |
| HQE1 (Frankfurt) / CTSO (NASDAQ) |
| FRA:HQE1, ETR:HQE1, HQE1:GR, NASDAQ:CTSO |
| - |
| http://www.cytosorbents.c.. |
|
Cytosorbents Corporation is a biotechnology company that specializes in advanced blood purification technologies designed to treat life-threatening conditions in intensive care units and other hospital settings. The company's flagship product, CytoSo..
>Volltext.. |
| 31.68 Mio. EUR |
| 51.15 Mio. EUR |
| 31.74 Mio. EUR |
| -10.78 Mio. EUR |
| -7.02 Mio. EUR |
| -0.11 EUR |
| 25.16 Mio. EUR |
| 5.35 Mio. EUR |
| -10.6 Mio. EUR |
| 0.64 |
| -8.22% |
| 65.12% |
| - |
| - |
| - |
| - |
| CYTOSORBENTS |
| 08.04.26 |
|